Abbonarsi

Ward based inhaler technique service reduces exacerbations of asthma and COPD - 19/10/21

Doi : 10.1016/j.rmed.2021.106583 
Toby GD. Capstick a, , Nooria F. Azeez a, Gary Deakin a, Ashleigh Goddard a, Dawn Goddard a, Ian J. Clifton b
a Medicines Management and Pharmacy Services, Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK 
b Leeds Teaching Hospitals NHS Trust, Department of Respiratory Medicine, Leeds, West Yorkshire, UK 

Corresponding author. Medicines Management and Pharmacy Services, St James's University Hospital, Becket Street, Leeds, West Yorkshire, LS9 7TF, UK.Medicines Management and Pharmacy ServicesSt James's University HospitalBecket StreetLeedsWest YorkshireLS9 7TFUK

Abstract

Background

The management of asthma and COPD is largely dependent on patients being able to use their inhaled medication correctly, but poor inhaler technique continues to be a recurring theme in studies and clinical practice. This is associated with poor disease control, increased risk of exacerbations and hospital admissions, and so there is a need to redesign services for patients to optimise their medicines use.

Methods

A novel ward-based dedicated inhaler technique service was developed, and pharmacy support workers trained to provide this, focusing on optimising inhaler technique using a checklist and recommending protocol-guided inhaler device switches. Inpatients on adult respiratory wards with a diagnosis of exacerbation of asthma or COPD consented to receive this service, and the impact on exacerbations and hospital admissions were compared in the 6-months before and after the intervention.

Results

266 adults (74 asthma, 188 COPD, and four asthma-COPD overlap) received the inhaler technique service. Six-month exacerbation and hospital admission data were available for 184 subjects. Optimising inhaler technique achieved a significant reduction in the combined asthma and COPD annualised rate of moderate-to-severe exacerbations (Rate Ratio [RR] 0.75, p < 0.05) and annualised rate of hospital admissions (RR 0.57, p < 0.0005). Improvements were also observed in future length of stay (- 1.6 days) and the average cost of admission (-£748).

Conclusions

This novel inhaler technique service produced a significant reduction in the rate of moderate-to-severe exacerbations of asthma and COPD, and a reduction in the rate hospital admissions, length of stay and average cost of admission.

Il testo completo di questo articolo è disponibile in PDF.

Highlights

Using inhaler devices correctly is critical for chronic lung disease management.
Poor inhaler technique continues to be a recurring theme in asthma and COPD.
A dedicated service can focus on teaching patients to use inhalers correctly.
Improving the use of inhalers prevents future exacerbations and hospital admissions.
Patients value the use of a dedicated service to teach correct inhaler use.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Asthma, COPD, Inhaler devices, Patient education, Pharmacy


Mappa


Crown Copyright © 2021  Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 187

Articolo 106583- ottobre 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Derivation and validation of a prediction model for histopathologic fibrotic hypersensitivity pneumonitis
  • Federica De Giacomi, Darin White, Paul A. Decker, Laszlo T. Vaszar, Nathan Sandbo, Augustine S. Lee, Jay H. Ryu, Teng Moua
| Articolo seguente Articolo seguente
  • Efficacy of mepolizumab in usual clinical practice and characteristics of responders
  • Carlota Rodríguez-García, Marina Blanco-Aparicio, Juan José Nieto-Fontarigo, Nagore Blanco-Cid, Coral Gonzalez-Fernandez, Mar Mosteiro-Añon, Uxío Calvo-Alvarez, Luis Perez-De-Llano, María Dolores Corbacho-Abelaira, Tamara Lourido-Cebreiro, Luis Miguel Dominguez-Juncal, Carlos Crespo-Diz, Raquel Dacal-Quintas, Abel Pallares-Sanmartin, David Dacal-Rivas, Francisco Javier Gonzalez-Barcala

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.